AI-enabled expansion Gator Bio has recently launched AI-designed binding protein probes (Gator HIS XT) and is pursuing collaborations with AI-driven design firms, signaling opportunity to cross-sell AI-accelerated biosensing and custom probe development to biotherapeutics customers.

Biolayer Interferometry Leader With validated performance across 400+ installations, multiple biosensor options, and competitive total economics, there is a strong value proposition to upsell advanced BLI probes and higher-throughput sensing solutions to existing labs using legacy platforms.

Strategic Partnerships Active collaborations with Bristol-Myers Squibb Korea, I&L Biosystems, and Solve Scientific, plus recent Monod Bio integration, create channel expansion and regional sales opportunities—target biotherapeutics, gene therapy firms, and contract research organizations.

Genome & Gene Tools Product launches around GeneSwift reagents for genome titer and genome integrity analysis indicate cross-sell potential into genome engineering groups, sequencing facilities, and regulatory-ready workflows seeking reliable, reproducible BLI-enabled readouts.

Customer-Centric Support PhD-level application support and a low-cost-of-operation with 20 regeneration cycles position Gator Bio as a trusted partner for labs focused on regulatory submissions and assay development, presenting opportunities for service contracts, training packages, and extended support agreements.